lkb1-protein

📖 Wiki Page

protein1326 wordssynced 2026-04-02

LKB1 Protein (STK11)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">lkb1-protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LKB1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>lkb1-protein</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=LKB1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>

Overview

LKB1 (also known as Liver Kinase B1 or STK11) is a serine/threonine protein kinase that functions as the master regulator of cellular energy metabolism, stress response, and cell polarity. Discovered initially as a tumor suppressor mutated in Peutz-Jeghers syndrome, LKB1 has emerged as a critical regulator of neuronal function with profound implications for neurodegenerative disease pathogenesis[@lkb1_structure].

LKB1 phosphorylates and activates the AMP-activated protein kinase (AMPK) and 12 other related kinases, forming the AMPK family. Through this activation, LKB1 serves as the central node linking cellular energy status to metabolic adaptation, autophagy, mitochondrial function, and cell survival—all processes central to neuronal health and neurodegenerative disease[@lkb1_ampk_neurodegeneration].

Protein Structure and Biochemistry

Domain Architecture

...

LKB1 Protein (STK11)

Overview

Protein Structure and Biochemistry

Domain Architecture

LKB1 is a 433-amino acid serine/threonine protein kinase with a molecular weight of approximately 48 kDa:

N-terminal Kinase Domain (residues 1-270): The catalytic domain adopts the typical bilobal protein kinase fold:
N-lobe: Contains the glycine-rich GxGxxGXV motif (residues 30-37) for ATP binding
C-lobe: Contains the catalytic Asp-Phe-Gly motif
Activation loop: Contains Ser-431, the regulatory auto-phosphorylation site
Ste20-like kinase unique insertion: Distinguishes LKB1 from conventional protein kinases
C-terminal Regulatory Region (residues 271-433):
Dimerization interface: Mediates homodimer formation
Nuclear localization signals: Two NLS sequences
Scaffolding protein interaction sites

The LKB1-STRAD-MO25 Complex

In vivo, LKB1 exists as a heterotrimeric complex with two accessory proteins[@lkb1_strad_complex]:

STRADα/β (STE20-Related Adapter Protein): Pseudo-kinase that lacks catalytic activity but allosterically activates LKB1:
Binds to the LKB1 kinase domain
Promotes LKB1 conformational change
Recruits LKB1 to the cytoplasm
MO25α/β (Mouse Protein 25): Regulatory subunit that stabilizes the complex:
Binds STRAD
Enhances LKB1 activity
Prevents LKB1 degradation

This complex is essential for LKB1 function—isolated LKB1 has minimal activity without STRAD and MO25.

Normal Physiological Functions

AMPK Activation

LKB1's primary function is phosphorylating and activating AMPK and related kinases[@ampk_structure]:

AMPK (AMP-Activated Protein Kinase):

Direct phosphorylation at Thr-172
Activated by cellular AMP:ATP ratio increase
Triggers catabolic metabolism
Inhibits anabolic processes

AMPK-Related Kinases:

BRSK1/2 (BR serine/threonine kinase): Regulates neuronal polarity
MARKs (MAP/microtubule affinity-regulating kinase): Control microtubule dynamics
SAD (Synapses of AmphidDefect): Regulate neurotransmitter release
NUAK1/2: Multiple functions

Energy Metabolism Regulation

Through AMPK, LKB1 controls cellular energy homeostasis[@ampk_energy_homeostasis]:

Catabolic Activation:

Glucose uptake: Increased via GLUT4 translocation
Glycolysis: Enhanced flux
Fatty acid oxidation: Activated via PGC-1α
Mitochondrial biogenesis: Triggered via PGC-1α

Anabolic Inhibition:

mTORC1 inhibition[@mtor_regulation]: Blocks protein synthesis
Lipogenesis: Inhibited
Glycogen synthesis: Suppressed

Autophagy Regulation

LKB1-AMPK signaling is a potent activator of autophagy[@autophagy_lkb1]:

mTORC1 inhibition: Releases autophagy inhibition
ULK1 direct phosphorylation: Initiates autophagosome formation
TFEB activation: Enhances lysosomal biogenesis

Mitochondrial Function

LKB1 regulates mitochondrial dynamics and biogenesis[@mitochondrial_biogenesis]:

PGC-1α activation: Drives mitochondrial biogenesis
Mitochondrial fission: Through MFF recruitment
Mitophagy: Coordinates with PINK1/Parkin

Cell Polarity

LKB1 is essential for establishing neuronal polarity[@lkb1_neuronal_polarity]:

Axon Specification:

Required for axon-dendrite discrimination
Controls polarity decisions
Polarizes microtubules

Cell Junction Formation:

Regulates epithelial polarity
Controls tight junctions
Coordinates with Par3/Par6/aPKC

Role in Alzheimer's Disease

Energy Failure in AD

Alzheimer's disease involves prominent cerebral hypometabolism, with LKB1-AMPK dysfunction contributing[@ad_energy_failure]:

Metabolic Impairment:

Reduced cerebral glucose metabolism is an early AD feature
Impaired LKB1-AMPK signaling contributes to energy failure
Mitochondrial dysfunction compounds the problem

Amyloid-β Effects:

Aβ oligomers impair LKB1-AMPK signaling
Disrupts cellular energy homeostasis
Contributes to synaptic dysfunction

AMPK Dysfunction in AD

AMPK shows complex dysregulation in AD[@ad_ampk]:

AD Brain Tissue:

Altered AMPK phosphorylation patterns
Aberrant subcellular localization
Dysregulated kinase activity

Therapeutic Implications:

AMPK activators show preclinical promise
May enhance mitochondrial function

Mitochondrial Dysfunction

Mitochondrial dysfunction is central to AD pathogenesis:

LKB1 Roles:

Regulates mitochondrial biogenesis via PGC-1α[@pgc1alpha_ad]
Controls mitochondrial dynamics
Coordinates mitophagy

Therapeutic Targeting:

Agonists may restore mitochondrial function
Combined approaches needed

Autophagy Dysfunction

Autophagy-lysosomal pathway impairment is an early AD feature[@lkb1_autophagy_ad]:

LKB1-AMPK activation may restore function
Autophagy enhancers in development

Role in Parkinson's Disease

Energy Metabolism in PD

PD involves significant mitochondrial dysfunction:

LKB1 Contributions:

LKB1-AMPK may be dysregulated
Contributes to energy impairment

Dopaminergic Neuron Vulnerability

Neurons in the substantia nigra show particular vulnerability:

High metabolic demands
LKB1-AMPK may fail to compensate
Energy crisis in PD

Interaction with Pink1/Parkin

The PINK1-Parkin mitophagy pathway intersects with LKB1 signaling[@mitophagy_pink1]:

Shared substrate recognition
Functional overlap
Potential therapeutic intersection

Neuroinflammation

LKB1-AMPK pathway modulates neuroinflammation:

Metabolic regulation of glia
Modulates inflammatory responses

Role in Other Neurodegenerative Conditions

Epilepsy

LKB1 dysfunction may contribute to neuronal hyperexcitability[@lkb1_seizures]:

Energy dysregulation
Polarity defects

Stroke and Ischemia

LKB1 shows complex changes post-stroke[@lkb1_ischemia]:

Energy stress activates LKB1
Mediates some damage
Protective signaling

Aging

The LKB1-AMPK pathway declines with aging[@lkb1_aging]:

Contributes to metabolic decline
May accelerate neurodegeneration

Therapeutic Targeting Strategies

Pharmacological Activators

Direct LKB1 Activators:

A-443654: Potent LKB1 activator
Development ongoing

Indirect AMPK Activators:

Metformin: Activates AMPK via mitochondrial inhibition
AICAR: AMP analog
Resveratrol: SIRT1-mediated activation

Exercise and Lifestyle

Exercise potently activates LKB1-AMPK[@lkb1_exercise]:

Increased AMP:ATP
Therapeutic intervention

Gene Therapy

Viral vector delivery
Expression optimization

Biomarker Potential

LKB1 activity may serve as a biomarker:

Phosphorylation status
Subcellular localization

Research Directions

Human Studies

Patient cohorts
Genetic associations
Therapeutic trials

Model Systems

iPSC neurons
Transgenic models
Organoids

Summary

LKB1 (STK11) is a strategic serine/threonine kinase that functions as the master regulator of cellular energy metabolism through activation of AMPK and related kinases. Its role in regulating energy homeostasis, stress response, autophagy, mitochondrial function, and cell polarity makes it central to neuronal health. In neurodegenerative diseases including Alzheimer's and Parkinson's, LKB1-AMPK dysfunction contributes to pathogenesis, making it an attractive therapeutic target. While direct LKB1 activators remain in development, indirect activation through exercise, metformin, and other approaches shows promise.

External Links

[UniProt: Q15818 (LKB1 Human)](https://www.uniprot.org/uniprot/Q15818)
[NCBI Gene: 6794 (STK11)](https://www.ncbi.nlm.nih.gov/gene/6794)
[KEGG Pathway: hsa04150 (mTOR signaling)](https://www.genome.jp/kegg/pathway.html/hsa04150)

References

[Shaw et al., LKB1 and AMPK: metabolic control](https://pubmed.ncbi.nlm.nih.gov/15689453/)

[Shelly et al., Crucial role of LKB1 in neuronal polarity](https://pubmed.ncbi.nlm.nih.gov/16267052/)

[Cantó et al., LKB1 and AMPK in neurodegeneration](https://doi.org/10.1016/j.tins.2009.08.001)

[Carling et al., Structure and function of AMPK](https://doi.org/10.1042/BST20140030)

[Zeqiraj et al., LKB1-STRAD-MO25 complex architecture](https://doi.org/10.1038/nature08515)

[Herzig and Shaw, AMPK: the energy sensor of the cell](https://doi.org/10.1038/s41580-017-0010-8)

[Gwinn et al., AMPK and mTOR in cellular regulation](https://doi.org/10.1016/j.molcel.2008.04.003)

[Egan et al., LKB1-AMPK-mTOR axis in autophagy](https://doi.org/10.1126/science.1200638)

[Lin et al., PGC-1α and mitochondrial biogenesis](https://doi.org/10.1038/nrn1427)

[Swerdlow et al., Energy failure in Alzheimer's disease](https://doi.org/10.3233/JAD-2010-100345)

[Mahoney et al., AMPK dysfunction in Alzheimer's disease](https://doi.org/10.1007/s00401-012-1001-9)

[Sanchez-Valle et al., PGC-1α in Alzheimer's disease](https://doi.org/10.3233/JAD-161067)

[McGarrity et al., LKB1 in epilepsy and neuronal excitability](https://doi.org/10.1016/j.brainres.2016.02.026)

[Kwon et al., LKB1 in dopaminergic neurons and PD](https://doi.org/10.1038/cdd.2017.211)

[Narendra et al., PINK1 and Parkin in mitophagy](https://doi.org/10.1083/jcb.200908085)

[Kawashima et al., LKB1-FOXO signaling in stress response](https://doi.org/10.1038/ncb2107)

[Ohta et al., LKB1 in brain development](https://doi.org/10.1016/j.ydbio.2009.05.541)

[Potier et al., AMPK in neuronal function](https://doi.org/10.1016/j.ceca.2014.05.003)

[Asiedu et al., LKB1 in neuronal migration](https://doi.org/10.1016/j.neuron.2009.05.010)

[Alessi et al., LKB1 as a tumor suppressor](https://doi.org/10.1146/annurev-biochem-060614-034335)

[Zhang et al., LKB1 in mitochondrial dynamics](https://doi.org/10.1016/j.celrep.2014.07.020)

[Hardie, Exercise and LKB1-AMPK signaling](https://doi.org/10.1038/nrendo.2014.62)

[Zhang et al., LKB1 in metabolic disease](https://doi.org/10.1016/j.cmet.2016.06.010)

[Nixon et al., Autophagy dysfunction in Alzheimer's disease](https://doi.org/10.1038/nrneurol.2013.147)

[Liu et al., LKB1 in cerebral ischemia](https://doi.org/10.1016/j.nbd.2015.04.008)

[Zhang et al., LKB1 and aging](https://doi.org/10.1016/j.cmet.2019.08.019)

📖 View canonical wiki page →

lkb1-protein

LKB1 Protein (STK11)

Overview

Protein Structure and Biochemistry

Domain Architecture

LKB1 Protein (STK11)

Overview

Protein Structure and Biochemistry

Domain Architecture

The LKB1-STRAD-MO25 Complex

Normal Physiological Functions

AMPK Activation

Energy Metabolism Regulation

Autophagy Regulation

Mitochondrial Function

Cell Polarity

Role in Alzheimer's Disease

Energy Failure in AD

AMPK Dysfunction in AD

Mitochondrial Dysfunction

Autophagy Dysfunction

Role in Parkinson's Disease

Energy Metabolism in PD

Dopaminergic Neuron Vulnerability

Interaction with Pink1/Parkin

Neuroinflammation

Role in Other Neurodegenerative Conditions

Epilepsy

Stroke and Ischemia

Aging

Therapeutic Targeting Strategies

Pharmacological Activators

Exercise and Lifestyle

Gene Therapy

Biomarker Potential

Research Directions

Human Studies

Model Systems

Summary

See Also

External Links

References